FARLUTAL

This brand name is authorized in Austria, Brazil, Estonia, Spain, Finland

Active ingredients

The drug FARLUTAL contains one active pharmaceutical ingredient (API):

1 Medroxyprogesterone
UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.

Read about Medroxyprogesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L02AB02 Medroxyprogesterone L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AB Progestogens
Discover more medicines within L02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522236201118418, 522236202114416
Country: EE Ravimiamet Identifier(s): 1013195
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 57258
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 161794

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.